investorscraft@gmail.com

Intrinsic ValueJiangsu Yangnong Chemical Co., Ltd. (600486.SS)

Previous Close$80.40
Intrinsic Value
Upside potential
Previous Close
$80.40

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Jiangsu Yangnong Chemical Co., Ltd. operates as a specialized agrochemical producer within China's basic materials sector, focusing primarily on the development, manufacturing, and distribution of pyrethroid-based pesticides. Its core revenue model is built on selling these chemical products for both agricultural applications, which protect crops from pests, and public health uses, such as mosquito control, serving a critical need in food security and disease prevention. The company has established a significant domestic footprint while also extending its market reach through exports, leveraging its integrated production capabilities and technical expertise in synthetic pyrethroids. Positioned as a key player in the agricultural inputs industry, Yangnong Chemical benefits from the essential nature of its products, though it operates in a competitive and regulated market that demands continuous innovation and strict compliance with environmental and safety standards.

Revenue Profitability And Efficiency

The company reported robust revenue of CNY 10.43 billion for the period, demonstrating strong market demand for its pesticide products. Net income reached CNY 1.20 billion, reflecting effective cost management and operational efficiency. Healthy operating cash flow of CNY 2.16 billion supports ongoing business activities and strategic investments, indicating solid cash generation from core operations.

Earnings Power And Capital Efficiency

Yangnong Chemical exhibits considerable earnings power with a diluted EPS of CNY 2.98. The significant positive operating cash flow, substantially exceeding net income, highlights strong quality of earnings and efficient conversion of profits into cash. Capital expenditures of CNY 1.84 billion indicate active investment in maintaining and potentially expanding production capacity.

Balance Sheet And Financial Health

The company maintains a conservative financial structure with cash and equivalents of CNY 1.62 billion providing ample liquidity. Total debt of CNY 1.19 billion appears manageable relative to its cash position and earnings capacity, suggesting a low-risk balance sheet. This financial stability supports operational flexibility and resilience against market fluctuations.

Growth Trends And Dividend Policy

The company demonstrates a shareholder-friendly approach through its dividend distribution of CNY 0.68 per share. While specific growth rates are not provided, the substantial revenue base and profitability indicate a mature yet stable operation. The balance between reinvestment through capital expenditures and returning capital to shareholders suggests a balanced growth and income strategy.

Valuation And Market Expectations

With a market capitalization of approximately CNY 29.72 billion, the market values the company at a multiple that reflects its position in the essential agricultural inputs sector. A beta of 0.991 indicates stock volatility closely aligned with the broader market, suggesting investors view it as a relatively stable investment within its sector despite cyclical agricultural demand patterns.

Strategic Advantages And Outlook

Yangnong Chemical's strategic advantage lies in its specialization in pyrethroids, essential products for crop protection and public health. Its integrated manufacturing and established market presence provide competitive moats. The outlook remains tied to global agricultural demand, regulatory environments, and the company's ability to maintain production efficiency and product efficacy in a evolving market.

Sources

Company Financial ReportsStock Exchange Disclosures

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount